Description
Product details
IMATIFLOW 400 Imatinib IP 400mg Cancer treatment has advanced significantly over the years, and targeted therapies have transformed outcomes for many patients. One such breakthrough medicine is Imatinib IP 400mg, marketed as IMATIFLOW 400. This medication is widely used in the treatment of certain types of cancers and blood disorders by targeting the underlying disease process at the molecular level. IMATIFLOW 400 is a trusted formulation of Imatinib that offers effective disease control while improving quality of life when used as prescribed under medical supervision. What Is Imatinib IP 400mg? Imatinib IP 400mg belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs). Unlike traditional chemotherapy that attacks rapidly dividing cells, Imatinib works by specifically blocking abnormal proteins responsible for cancer cell growth. IMATIFLOW 400 is primarily prescribed for: Chronic Myeloid Leukemia (CML) Gastrointestinal Stromal Tumors (GIST) Certain rare blood and bone marrow disorders By acting at the root cause of disease, Imatinib IP 400mg has become a cornerstone of modern targeted cancer therapy. How IMATIFLOW 400 Works IMATIFLOW 400 works by inhibiting abnormal tyrosine kinase enzymes that signal cancer cells to grow and multiply uncontrollably. Mechanism of Action: Cancer cells produce abnormal proteins due to genetic mutations These proteins send continuous growth signals Imatinib blocks these signals Cancer cell growth slows down or stops Diseased cells gradually die while healthy cells are largely spared This targeted approach makes IMATIFLOW 400 more precise and often better tolerated compared to conventional chemotherapy. Uses of Imatinib IP 400mg (IMATIFLOW 400) 1. Chronic Myeloid Leukemia (CML) IMATIFLOW 400 is widely used as a first-line treatment for patients with Philadelphia chromosome-positive CML. It helps control disease progression and allows many patients to live longer, more stable lives. 2. Gastrointestinal Stromal Tumors (GIST) In patients with inoperable or metastatic GIST, Imatinib IP 400mg helps shrink tumors and prevent further growth. 3. Acute Lymphoblastic Leukemia (ALL) In certain cases of Philadelphia chromosome-positive ALL, IMATIFLOW 400 is used as part of combination therapy. 4. Other Rare Conditions IMATIFLOW 400 may also be prescribed for: Myelodysplastic syndromes Hypereosinophilic syndrome Certain dermatological and hematological disorders Key Benefits of IMATIFLOW 400 Targeted Cancer Therapy IMATIFLOW 400 targets cancer cells at a molecular level, reducing unnecessary damage to healthy cells. Improved Survival Rates Long-term studies show that Imatinib significantly improves survival and disease control in CML and GIST patients. Oral Administration Unlike injectable chemotherapy, IMATIFLOW 400 is taken orally, making treatment more convenient. Better Quality of Life Patients often experience fewer severe side effects compared to traditional cancer therapies. Long-Term Disease Management Many patients remain on Imatinib therapy for years with stable disease control. Advantages of IMATIFLOW 400 Over Conventional Chemotherapy Specific action on cancer-causing proteins Lower toxicity profile Reduced hospital visits Improved patient compliance Suitable for long-term treatment These advantages make IMATIFLOW 400 a preferred choice in targeted oncology care. Dosage and Administration The usual dose of Imatinib IP 400mg is one tablet once daily Should be taken with food and a full glass of water Dosage may vary depending on disease type, stage, and patient response Always follow the oncologist’s instructions strictly Do not stop or adjust the dose without medical advice, as this may affect treatment outcomes. Side Effects of Imatinib IP 400mg Like all medicines, IMATIFLOW 400 may cause side effects, although not everyone experiences them. Common Side Effects Nausea and vomiting Diarrhea Muscle cramps Fatigue Headache Swelling around eyes or ankles Mild skin rash These side effects are usually manageable and improve as the body adjusts to the medicine. Serious Side Effects Although uncommon, some patients may experience serious side effects, including: Severe fluid retention Liver function abnormalities Low blood cell counts Severe skin reactions Heart-related complications (rare) Immediate medical attention is required if severe symptoms occur. Precautions and Warnings Regular blood tests are required during treatment Liver function monitoring is important Inform the doctor about all other medicines being taken Use with caution in patients with heart or liver disease Not recommended during pregnancy unless clearly advised Breastfeeding should be avoided during treatment Drug Interactions IMATIFLOW 400 may interact with: Certain antibiotics Antifungal medicines Blood thinners Herbal supplements like St. John’s Wort Always inform your doctor about any medication or supplement you are using. Who Should Take IMATIFLOW 400? Patients diagnosed with CML Patients with GIST Individuals prescribed targeted therapy by an oncologist Patients requiring long-term cancer management Storage Instructions Store at room temperature Keep away from moisture and heat Keep out of reach of children Do not use after the expiry date Frequently Asked Questions Is IMATIFLOW 400 chemotherapy? No, it is a targeted therapy, not traditional chemotherapy. How long should Imatinib IP 400mg be taken? Treatment duration depends on disease response and medical advice. Some patients take it long-term. Can IMATIFLOW 400 cure cancer? It helps control and manage cancer effectively, and in many cases keeps the disease in remission. Is IMATIFLOW 400 safe for long-term use? Yes, when monitored regularly under medical supervision. Conclusion IMATIFLOW 400 (Imatinib IP 400mg) represents a major advancement in cancer treatment through its targeted mechanism of action. By directly blocking the proteins responsible for cancer growth, it offers effective disease control with improved tolerability. When taken correctly and under medical guidance, IMATIFLOW 400 can significantly enhance survival, stability, and quality of life for patients battling chronic and complex cancers.
